The landscape of diabetes management is rapidly shifting, with the emergence of dual GIP and GLP-1 receptor agonists. Both Tirzepatide and Retatrutide represent significant advancements; Tirzepatid already https://retatrutide-20mg-uk789707.bloggerchest.com/profile